Medipharm Labs Corp T.LABS

Big implications for MPL

[alleyesonme]

Remember this...On the global scale, there are certainly considerations that will need to be made as the change relates to the single convention on psychotropic substances but there’s also potential opportunity for international cannabis manufacturers in the United States. As was just referenced one of the areas that state cannabis production may struggle is upgrading their production environments to a GMP standard. As it stands presently there is only one public cannabis company that has completed FDA inspections and has delivered approved research material to American researchers. This company is MediPharm Labs based in Ontario, Canada.https://businessofcannabis.com/us-reschedule-cannabis-drug-policy-opportunities-industry/